Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR LLC | 2,800,985 11.085% |
-86,753 (-3.00%) |
Filing History |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR LLC | 2,887,738 11.493% |
2,887,738 (New Position) |
Filing History |
| 2021-02-22 6:31 pm Purchase |
2021-02-09 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 3,791,204 15.100% |
3,791,204 (New Position) |
Filing History |
| 2021-02-18 4:53 pm Purchase |
2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
Vivo Capital VIII, LLC | 2,317,780 9.700% |
2,317,780 (New Position) |
Filing History |
| 2021-02-09 2:21 pm Purchase |
2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
James E. Flynn | 2,382,033 9.940% |
2,382,033 (New Position) |
Filing History |